EdgarLookup

Abacus Global Management, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Abacus Global Management, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
15.5%
Profit Margin
Net income ÷ revenue
4%
Return on Assets
Net income ÷ assets
-26.03x
Debt-to-Equity
Total liabilities ÷ equity
+110.2%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $235.24M Mar 13, 2026
FY2025 Dec 31, 2024 $111.92M Mar 13, 2026
FY2024 Dec 31, 2023 $66.40M Mar 28, 2025
FY2023 Dec 31, 2022 $44.71M May 30, 2024

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $235.24M Mar 13, 2026
FY2025 Dec 31, 2024 $111.92M Mar 13, 2026

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $206.38M Mar 13, 2026
FY2025 Dec 31, 2024 $100.55M Mar 13, 2026
FY2024 Dec 31, 2023 $59.91M Mar 28, 2025
FY2023 Dec 31, 2022 $38.83M May 30, 2024

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $36.53M Mar 13, 2026
FY2025 Dec 31, 2024 ($23.96M) Mar 13, 2026
FY2024 Dec 31, 2023 $9.52M Mar 28, 2025
FY2023 Dec 31, 2022 $31.68M May 30, 2024
FY2022 Dec 31, 2021 $15.84M Apr 18, 2023
FY2021 Dec 31, 2020 ($10.80M) Jun 22, 2022
FY2020 Sep 30, 2020 $4.95M Jul 16, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $88.76M Mar 13, 2026
FY2025 Dec 31, 2024 ($888.3K) Mar 13, 2026
FY2024 Dec 31, 2023 $24.13M Mar 28, 2025
FY2023 Dec 31, 2022 $33.67M May 30, 2024

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($25.68M) Mar 13, 2026
FY2025 Dec 31, 2024 ($208.81M) Mar 13, 2026
FY2024 Dec 31, 2023 ($64.04M) Mar 28, 2025
FY2023 Dec 31, 2022 $10.69M May 30, 2024
FY2022 Dec 31, 2021 ($1.24M) Apr 18, 2023
FY2021 Dec 31, 2020 ($570.1K) Jun 22, 2022

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $931.4K Mar 13, 2026
FY2025 Dec 31, 2024 $786.2K Mar 13, 2026
FY2024 Dec 31, 2023 $189.7K Mar 28, 2025
FY2023 Dec 31, 2022 $0 May 30, 2024

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $902.24M Mar 13, 2026
FY2025 Dec 31, 2024 $874.16M Mar 13, 2026
FY2024 Dec 31, 2023 $331.83M Mar 28, 2025
FY2023 Dec 31, 2022 $59.09M May 30, 2024
FY2022 Dec 31, 2021 $345.99M Apr 18, 2023
FY2021 Dec 31, 2020 $345.85M Jun 22, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $478.70M Mar 13, 2026
FY2025 Dec 31, 2024 $450.87M Mar 13, 2026
FY2024 Dec 31, 2023 $167.76M Mar 28, 2025
FY2023 Dec 31, 2022 $30.95M May 30, 2024
FY2022 Dec 31, 2021 $29.23M Apr 18, 2023
FY2021 Dec 31, 2020 $44.93M Jun 22, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 ($18.39M) Apr 18, 2023
FY2022 Dec 31, 2021 ($28.24M) Apr 18, 2023
FY2022 Dec 31, 2020 ($44.08M) Apr 18, 2023

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $252.78M Mar 13, 2026
FY2025 Dec 31, 2024 $238.30M Mar 13, 2026
FY2024 Dec 31, 2023 $140.29M Mar 28, 2025
FY2023 Dec 31, 2022 $0 May 30, 2024

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($41.63M) Mar 13, 2026
FY2025 Dec 31, 2024 ($57.90M) Mar 13, 2026
FY2024 Dec 31, 2023 ($34.73M) Mar 28, 2025
FY2023 Dec 31, 2022 $25.49M May 30, 2024
FY2022 Dec 31, 2021 ($28.26M) Apr 18, 2023
FY2021 Dec 31, 2020 ($44.10M) Jun 22, 2022
FY2020 Sep 30, 2020 ($28.36M) Jul 16, 2021
FY2020 Jul 27, 2020 ($74.92M) Jul 16, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $38.11M Mar 13, 2026
FY2025 Dec 31, 2024 $131.94M Mar 13, 2026
FY2024 Dec 31, 2023 $25.59M Mar 28, 2025
FY2023 Dec 31, 2022 $30.05M May 30, 2024

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $405.82M Mar 13, 2026
FY2025 Dec 31, 2024 $380.82M Mar 13, 2026

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 13, 2026
FY2025 Dec 31, 2024 0 Mar 13, 2026
FY2024 Dec 31, 2023 0 Mar 28, 2025
FY2023 Dec 31, 2022 0 May 30, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 13, 2026
FY2025 Dec 31, 2024 0 Mar 13, 2026
FY2024 Dec 31, 2023 0 Mar 28, 2025
FY2023 Dec 31, 2022 0 May 30, 2024

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 97.47M Mar 13, 2026
FY2025 Dec 31, 2024 95.68M Mar 13, 2026
FY2024 Dec 31, 2023 63.24M Mar 28, 2025
FY2023 Dec 31, 2022 50.37M May 30, 2024

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $19.55M Mar 13, 2026
FY2025 Dec 31, 2024 $0 Mar 13, 2026